BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33175462)

  • 21. Detection of changes in synaptic density in amyotrophic lateral sclerosis patients using
    Tang Y; Liu P; Li W; Liu Z; Zhou M; Li J; Yuan Y; Fang L; Wang M; Shen L; Huang Y; Tang B; Wang J; Hu S
    Eur J Neurol; 2022 Oct; 29(10):2934-2943. PubMed ID: 35708508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDG-PET shows weak correlation between focal motor weakness and brain metabolic alterations in ALS.
    Sennfält S; Pagani M; Fang F; Savitcheva I; Estenberg U; Ingre C
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 Aug; 24(5-6):485-494. PubMed ID: 36755485
    [No Abstract]   [Full Text] [Related]  

  • 23. Is there a glucose metabolic signature of spreading TDP-43 pathology in amyotrophic lateral sclerosis?
    van Weehaeghe D; Ceccarini J; Willekens SM; de Vocht J; van Damme P; van Laere K
    Q J Nucl Med Mol Imaging; 2020 Mar; 64(1):96-104. PubMed ID: 29166751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis.
    Sala A; Iaccarino L; Fania P; Vanoli EG; Fallanca F; Pagnini C; Cerami C; Calvo A; Canosa A; Pagani M; Chiò A; Cistaro A; Perani D
    Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1117-1131. PubMed ID: 30617963
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Yuan F; Yu J; Liao G; Li J; Long T; Li Y; Chen D; Dai Q; Zhu X; Hu S; Qian Z
    Addict Biol; 2021 Sep; 26(5):e13043. PubMed ID: 33908137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional prefrontal cortical atrophy predicts specific cognitive-behavioral symptoms in ALS-FTD.
    Ratti E; Domoto-Reilly K; Caso C; Murphy A; Brickhouse M; Hochberg D; Makris N; Cudkowicz ME; Dickerson BC
    Brain Imaging Behav; 2021 Oct; 15(5):2540-2551. PubMed ID: 33587281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics.
    Van Weehaeghe D; Devrome M; Schramm G; De Vocht J; Deckers W; Baete K; Van Damme P; Koole M; Van Laere K
    Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2681-2690. PubMed ID: 32314027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypometabolic and hypermetabolic brain regions in patients with ALS-FTD show distinct patterns of grey and white matter degeneration: A pilot multimodal neuroimaging study.
    Rajagopalan V; Pioro EP
    Eur J Radiol; 2023 Jan; 158():110616. PubMed ID: 36493498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation.
    Castelnovo V; Caminiti SP; Riva N; Magnani G; Silani V; Perani D
    Neurol Sci; 2019 Mar; 40(3):515-521. PubMed ID: 30554355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ECAS correlation with metabolic alterations on FDG-PET imaging in ALS.
    Foucher J; Öijerstedt L; Lovik A; Sun J; Ismail MA; Sennfält S; Savitcheva I; Estenberg U; Pagani M; Fang F; Pereira JB; Ingre C
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Jun; ():1-9. PubMed ID: 38836336
    [No Abstract]   [Full Text] [Related]  

  • 31. Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis.
    Canosa A; D'Ovidio F; Calvo A; Moglia C; Manera U; Torrieri MC; Vasta R; Cistaro A; Gallo S; Iazzolino B; Nobili FM; Casale F; Chiò A; Pagani M
    Neuroimage Clin; 2020; 27():102312. PubMed ID: 32622315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron emission tomography metabolic correlates of apathy in Alzheimer disease.
    Marshall GA; Monserratt L; Harwood D; Mandelkern M; Cummings JL; Sultzer DL
    Arch Neurol; 2007 Jul; 64(7):1015-20. PubMed ID: 17620493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different apathy clinical profile and neural correlates in behavioral variant frontotemporal dementia and Alzheimer's disease.
    Fernández-Matarrubia M; Matías-Guiu JA; Cabrera-Martín MN; Moreno-Ramos T; Valles-Salgado M; Carreras JL; Matías-Guiu J
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):141-150. PubMed ID: 28240379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P11 expression and PET in bipolar disorders.
    Zhang L; Li CT; Su TP; Hu XZ; Lanius RA; Webster MJ; Chung MY; Chen YS; Bai YM; Barker JL; Barrett JE; Li XX; Li H; Benedek DM; Ursano R
    J Psychiatr Res; 2011 Nov; 45(11):1426-31. PubMed ID: 21722919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease.
    Agosta F; Altomare D; Festari C; Orini S; Gandolfo F; Boccardi M; Arbizu J; Bouwman F; Drzezga A; Nestor P; Nobili F; Walker Z; Pagani M;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1546-1556. PubMed ID: 29717332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow-metabolism uncoupling in the cervical spinal cord of ALS patients.
    Yamashita T; Hatakeyama T; Sato K; Fukui Y; Hishikawa N; Ohta Y; Nishiyama Y; Kawai N; Tamiya T; Abe K
    Neurol Sci; 2017 Apr; 38(4):659-665. PubMed ID: 28120243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voxel-based mapping of grey matter volume and glucose metabolism profiles in amyotrophic lateral sclerosis.
    Buhour MS; Doidy F; Mondou A; Pélerin A; Carluer L; Eustache F; Viader F; Desgranges B
    EJNMMI Res; 2017 Dec; 7(1):21. PubMed ID: 28266002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and metabolic brain correlates of apathy in Huntington's disease.
    Martínez-Horta S; Perez-Perez J; Sampedro F; Pagonabarraga J; Horta-Barba A; Carceller-Sindreu M; Gomez-Anson B; Lozano-Martinez GA; Lopez-Mora DA; Camacho V; Fernández-León A; Carrió I; Kulisevsky J
    Mov Disord; 2018 Jul; 33(7):1151-1159. PubMed ID: 29676484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28.
    Zürcher NR; Loggia ML; Lawson R; Chonde DB; Izquierdo-Garcia D; Yasek JE; Akeju O; Catana C; Rosen BR; Cudkowicz ME; Hooker JM; Atassi N
    Neuroimage Clin; 2015; 7():409-14. PubMed ID: 25685708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.